tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ALKS Stock Latest News

Alkermes Advances Orexin Program with ALKS 2680 Candidate
Company AnnouncementsAlkermes Advances Orexin Program with ALKS 2680 Candidate
8d ago
8K
ALKS
Alkermes Prepares for New Flexibility Post Credit Termination
PremiumCompany Announcements
Alkermes Prepares for New Flexibility Post Credit Termination
1M ago
8K
ALKS
Alkermes Aims for Growth with Neuroscience Focus
PremiumCompany Announcements
Alkermes Aims for Growth with Neuroscience Focus
2M ago
8K
ALKS
Alkermes price target raised to $31 from $28 at BofA
PremiumThe Fly
Alkermes price target raised to $31 from $28 at BofA
2M ago
ALKS
CNTA
Alkermes price target raised to $40 from $35 at Mizuho
PremiumThe Fly
Alkermes price target raised to $40 from $35 at Mizuho
2M ago
ALKS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
RDY
TAK
Stifel bullish on orexin, upgrades Alkermes to Buy
Premium
The Fly
Stifel bullish on orexin, upgrades Alkermes to Buy
3M ago
TAK
ALKS
Alkermes upgraded to Buy from Hold at Stifel
Premium
The Fly
Alkermes upgraded to Buy from Hold at Stifel
3M ago
ALKS
Alkermes price target lowered to $28 from $29 at BofA
PremiumThe Fly
Alkermes price target lowered to $28 from $29 at BofA
3M ago
ALKS
Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald
PremiumThe Fly
Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald
3M ago
ALKS
Alkermes price target lowered to $30 from $32 at Goldman Sachs
PremiumThe Fly
Alkermes price target lowered to $30 from $32 at Goldman Sachs
3M ago
ALKS
Alkermes price target lowered to $37 from $38 at Piper Sandler
PremiumThe Fly
Alkermes price target lowered to $37 from $38 at Piper Sandler
3M ago
ALKS
Alkermes backs FY24 financial expectations
PremiumThe FlyAlkermes backs FY24 financial expectations
3M ago
ALKS
Alkermes reports Q3 adjusted EPS 72c, consensus 74c
Premium
The Fly
Alkermes reports Q3 adjusted EPS 72c, consensus 74c
3M ago
ALKS
ALKS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALKS Upcoming Earnings Report: What to Expect?
3M ago
ALKS
Alkermes orexin Franchise can be ‘transformative,’ says H.C. Wainwright
PremiumThe Fly
Alkermes orexin Franchise can be ‘transformative,’ says H.C. Wainwright
3M ago
ALKS
Alkermes Unveils Orexin Portfolio for Sleep Disorders
PremiumCompany Announcements
Alkermes Unveils Orexin Portfolio for Sleep Disorders
3M ago
8K
ALKS
Alkermes management to meet with Piper Sandler
PremiumThe Fly
Alkermes management to meet with Piper Sandler
4M ago
ALKS
Alkermes to present clinical data from its Phase 1b study of ALKS 2680
PremiumThe Fly
Alkermes to present clinical data from its Phase 1b study of ALKS 2680
4M ago
ALKS
Mizuho says hard to tell yet how Centessa and Alkermes stack up in narcolepsy
PremiumThe FlyMizuho says hard to tell yet how Centessa and Alkermes stack up in narcolepsy
4M ago
ALKS
CNTA
Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680
Premium
The Fly
Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680
5M ago
ALKS
Fulcrum appoints Isabel Kalofonos as CCO
Premium
The Fly
Fulcrum appoints Isabel Kalofonos as CCO
5M ago
ALKS
FULC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >